載入...
The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting
Background: Patients with gastric cancer benefit from perioperative chemotherapy, however, treatment is toxic and many patients will relapse. The trifunctional antibody catumaxomab targets EpCAM on tumor cells, CD3 on T cells, and the Fcγ-receptor of antigen-presenting cells. While in Europe catumax...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Landes Bioscience
2013
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4162043/ https://ncbi.nlm.nih.gov/pubmed/23955093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.26065 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|